GlassScriptPhysician profile
Matthew Grove
NPI 1659807428
$7,914.93
in general payments reported to CMS, 2019-2025
6 companies · $3,204 in 2025
The $3,204 reported for 2025 was more than what 81% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $857 · 2023: $606 · 2024: $3,247 · 2025: $3,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,225 · Travel and Lodging: $2,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,224.96 |
| Travel and Lodging | $2,832.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,137.70 | 2022-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Icefx Cryoablation System, General - Embolics |
| Medtronic, INC. | $338.29 | 2022 | |
| Inari Medical, INC. | $180.30 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $174.87 | 2025 | Indigo System, Ruby Coil |
| Stryker Corporation | $69.40 | 2022-2024 | Augment Injectable |
| Irhythm Technologies, INC. | $14.37 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Grove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.